Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > LMAO

<< Previous

Bullboard Posts

Next >>

Comment by TitanBrawleron Dec 28, 2022 1:53pm

148 Views

Post# 35193951

RE:RE:LMAO

1st off..
I said well under 2 bucks , duumbell.

And Buck is right on point when he said..

Why buy at 2 bucks when you can buy at 1 buck..

And don't be fooled about the temporary recovery of 10 cents.
It's being bought by the pathetic pumpers.
LMAO.

<< Previous

Bullboard Posts

Next >>

A Look into the Future of Chronic Pain Management